Brian Armstrong’s NewLimit Raises $435M for Human Trials

NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.

By Rony Roy

Publisher : crypto

Date : June 3, 2026

By Shiraz Jagati

Publisher : news

Date : June 3, 2026

By Rony Roy

Publisher : crypto

Date : June 3, 2026

By Ananda Banerjee

Publisher : beincrypto

Date : June 3, 2026

By Olivier Acuna

Publisher : coindesk

Date : June 3, 2026

Latest News